Vermont § 4233b - Xylazine

§ 4233b. Xylazine

• (a) No person shall dispense or sell xylazine except as provided in subsection (b) of
  this section. (b) The following are permitted activities related to xylazine: (1) dispensing or prescribing for, or administration to, a nonhuman species a drug containing
  xylazine approved by the Secretary of Health and Human Services pursuant to section
  512 of the Federal Food, Drug, and Cosmetic Act as provided in 21 U.S.C. § 360b; (2) dispensing or prescribing for, or administration to, a nonhuman species permissible
  pursuant to section 512(a)(4) of the Federal Food, Drug, and Cosmetic Act as provided
  in 21 U.S.C. § 360b(a)(4); (3) manufacturing, distribution, or use of xylazine as an active pharmaceutical ingredient
  for manufacturing an animal drug approved under section 512 of the Federal Food, Drug,
  and Cosmetic Act as provided in 21 U.S.C. § 360b or issued an investigation use exemption pursuant to section 512(j); (4) manufacturing, distribution, or use of a xylazine bulk chemical for pharmaceutical
  compounding by licensed pharmacists or veterinarians; and (5) any other use approved or permissible under the Federal Food, Drug, and Cosmetic Act. (c) A person knowingly and unlawfully dispensing xylazine shall be imprisoned not more
  than three years or fined not more than $75,000.00, or both. A person knowingly and
  unlawfully selling xylazine shall be imprisoned not more than five years or fined
  not more than $100,000.00, or both. (d) As used in this section, “knowingly” means: (1) the defendant had actual knowledge that one or more preparations, compounds, mixtures,
  or substances contained xylazine; or (2) the defendant: (A) was aware that there is a high probability that one or more preparations, compounds,
  mixtures, or substances contained xylazine; and (B) took deliberate actions to avoid learning that one or more preparations, compounds,
  mixtures, or substances contained xylazine. (Added 2023, No. 125 (Adj. Sess.), § 16, eff. July 1, 2024.)